Table 3.
Event | All Cases | Nonfatal | Fatal | P Value |
---|---|---|---|---|
Day of symptoms of first doctor visit | Day 2 (1–11) | Day 2 (1–11) | Day 2 (1–7) | |
Day of symptoms that RMSF was first mentioned in medical record | Day 3 (1–14) | Day 3 (1–14) | Day 7 (1–9) | .005 |
Day of symptoms that doxycycline was started | Day 3 (1–14) | Day 3 (1–14) | Day 7 (6–9) | .000 |
Duration between first mention and treatment | 0 days (0–10) | 0 days (0–10) | 0 days (0–5) | |
Day of symptoms hospitalization occurred | Day 5 (1–11) | Day 4 (1–11) | Day 5 (1–9) | |
Day of symptoms first CBC was obtained | Day 3 (1–14) | Day 3 (1–14) | Day 5.5 (1–9) | .008 |
Day of symptoms sodium was first tested | Day 3 (1–12) | Day 3 (1–12) | Day 5 (1–9) | .017 |
Day of symptoms AST was first tested | Day 3 (1–14) | Day 3 (1–14) | Day 7 (1–9) | .006 |
Day of symptoms that death occurred | NA | NA | Day 9 (6–20) |
Data are presented as median (range).
Abbreviations: AST, aspartate aminotransferase; CBC, complete blood count; NA, not applicable; RMSF, Rocky Mountain spotted fever.